Non-healing Wound Clinical Trial
Official title:
A Clinical Study to Evaluate the Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies
The goal of this clinical trial is to evaluate the use of Omeza combination therapy with Standard of Care. The main question it aims to answer is: - Can Omeza combination therapy with Standard of Care enable chronic wounds to begin a healing trajectory in a 4-week period? Patients will be treated with: - Omeza combination therapy - Standard of Care
The goal of this clinical trial is to demonstrate that the Omeza combination therapy with Standard of Care can enable chronic wounds to move from chronicity to a healing trajectory in a 4-week period. The trial is targeting those wounds that have failed therapy for approximately 3 months prior to trial enrollment and are chronic by definition of no change in area size after 2 weeks of optimal treatment. The inclusion and exclusion criteria applied to chronic wound clinical trials is being broadened with the intention to include outliers, reduce bias, and to evaluate results in a real-world scenario. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03632031 -
Treatment of Wounds Using Oasis® ECM
|
||
| Completed |
NCT03230175 -
Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)
|
Phase 2 | |
| Completed |
NCT04483934 -
Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts
|
Phase 1/Phase 2 | |
| Terminated |
NCT04134143 -
Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers
|
Phase 1 | |
| Recruiting |
NCT04450693 -
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
|
Phase 3 | |
| Not yet recruiting |
NCT06327113 -
Antibiotic Tumescent For Chronic Wounds
|
Phase 2 | |
| Not yet recruiting |
NCT03049670 -
The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study
|
N/A | |
| Not yet recruiting |
NCT05766982 -
Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)
|
N/A | |
| Active, not recruiting |
NCT04176120 -
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)
|
Phase 3 | |
| Completed |
NCT02657876 -
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
|
Phase 1 | |
| Not yet recruiting |
NCT06109844 -
FORCEREPAIR - A Wound Exudate Investigation
|
||
| Terminated |
NCT04240574 -
Debritom - Micro Water Jet Technology and Wound Healing
|
N/A | |
| Completed |
NCT05154838 -
Development of Volatile Organic Compounds (VOC) Analysis as a Potential Diagnostic for Infected and Non-Healing Wounds
|
||
| Not yet recruiting |
NCT03732365 -
Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds
|
Phase 2 | |
| Not yet recruiting |
NCT05251480 -
Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People
|
N/A | |
| Completed |
NCT04344483 -
Effect of Lidocaine and Adrenaline Soaked Gauze Versus Normal Saline Soaked at Skin Graft Donor Site of Thigh
|
N/A | |
| Recruiting |
NCT05739149 -
A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers
|
N/A | |
| Completed |
NCT03863054 -
An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the Rates of Healing of Chronic Diabetic Foot Ulcers
|
||
| Recruiting |
NCT06028386 -
Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
|
N/A | |
| Enrolling by invitation |
NCT06328010 -
An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers
|